Novel Halogenated Pyrazine-Based Chalcones as Potential Antimicrobial Drugs

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antimicrobial Research

Background:

• Chalcones (1,3-diphenylprop-2-en-1-ones) possess diverse biological activities, including antioxidant, anti-inflammatory, and anti-infective properties.
• Previous research focused on pyrazine analogues of chalcones, identifying electron-withdrawing groups (EWGs) on ring B as key for enhanced potency.
• Halogens, known for their electron-withdrawing properties, were investigated as substituents to synthesize novel chalcone derivatives.

Purpose of the Study:

• To synthesize novel halogenated chalcone derivatives via Claisen-Schmidt condensation.
• To evaluate the in vitro antifungal, antibacterial, and antimycobacterial activities of the synthesized compounds.
• To identify specific structural features, such as halogen substitution, that correlate with antimicrobial potency.

Main Methods:

• Synthesis of novel halogenated chalcone derivatives using Claisen-Schmidt condensation.
• Antifungal assays against eight fungal strains, including Candida glabrata and Trichophyton interdigitale.
• Antibacterial assays against selected bacterial strains, including Staphylococcus species.
• Antimycobacterial screening against Mycobacterium tuberculosis, M. kansasii, M. avium, and M. smegmatis.

Main Results:

• Non-alkylated derivatives with 2-bromo or 2-chloro substitution demonstrated growth inhibition against Candida glabrata and Trichophyton interdigitale.
• 2-chloro derivatives exhibited the highest inhibitory effect on Staphylococcus species.
• Several compounds showed significant antimycobacterial activity against Mycobacterium kansasii and Mycobacterium smegmatis, with minimum inhibitory concentrations (MICs) comparable to isoniazid.

Conclusions:

• Halogenated chalcone derivatives, particularly those with 2-chloro substitution, possess promising antifungal and antibacterial activities.
• The synthesized compounds represent a valuable new class of antimicrobial agents with potential against resistant strains.
• Further investigation into these halogenated chalcones could lead to the development of novel therapeutic agents for infectious diseases.